Biora Therapeutics, Inc. Financial Flexibility Index
Biora Therapeutics, Inc. financial flexibility index. Biora Therapeutics, Inc. (BIORQ) has a Financial Flexibility Index of -0.07x as of September 2024. Free cash flow of $-8.71 Million (operating CF $-8.73 Million minus capex $19.00K) represents 0% of total liabilities ($121.13 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Biora Therapeutics, Inc. (2018–2023)
Financial flexibility index of Biora Therapeutics, Inc. from 2018 to 2023. Historical Financial Flexibility Index trend for Biora Therapeutics, Inc. across 6 annual periods. Check Biora Therapeutics, Inc. cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Biora Therapeutics, Inc. Financial Flexibility Index by Year (2018–2023)
Biora Therapeutics, Inc. financial flexibility index by year from 2018 to 2023. Year-by-year free cash flow to debt coverage for Biora Therapeutics, Inc.. For the full cash flow conversion analysis, see Biora Therapeutics, Inc. (BIORQ) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.36x | $-48.40 Million | $-48.50 Million | $132.64 Million | ▲ +10.6% |
| 2022 | -0.41x | $-63.62 Million | $-64.42 Million | $155.81 Million | ▲ +52.5% |
| 2021 | -0.86x | $-166.63 Million | $-167.49 Million | $193.81 Million | ▼ -39.8% |
| 2020 | -0.62x | $-160.80 Million | $-165.74 Million | $261.43 Million | ▼ -11.5% |
| 2019 | -0.55x | $-102.40 Million | $-106.12 Million | $185.60 Million | ▼ -40.3% |
| 2018 | -0.39x | $-60.29 Million | $-65.13 Million | $153.37 Million | — |